Biomarkers of cardiac function and outcome in univentricular congenital heart disease
Harold S Bernstein,1,2 Hythem Nawaytou3
1Merck Sharp & Dohme Corp, Whitehouse Station, NJ, USA; 2The Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; 3Department of Pediatrics, University of California, San Francisco, CA, USA
Abstract: A biomarker is a clinical characteristic that predicts the presence of a specific physiological state, degree of severity of a pathophysiological state, or long-term outcome resulting from that state. Broadly defined, a biomarker can be a clinical parameter, or the result of a biochemical assay or imaging measure. Children are imperfect historians and cardiac disease may mimic other organ system diseases. Hence, reliable biomarkers can greatly enhance diagnosis and management of pediatric cardiac disease. In this review, we discuss the use of biomarkers in managing complex congenital heart disease characterized by single ventricle physiology.
Keywords: biomarker, natriuretic peptide, heart failure, congenital heart disease, single ventricle
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]